Continuous Transfection Cocktail Delivery for AAV Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
At industrial scales, the delay in preparing and delivering large volumes of transfection cocktail to cells reduces transfection efficiency due to increased particle size and potential toxicity, making it challenging to maintain high levels of genetic material uptake and productivity for biological products like gene therapy vectors.
Innovation Solution
The method involves preparing and delivering transfection cocktail continuously, ensuring thorough mixing of transfection reagent and nucleic acid, and rapid delivery to cells, with controlled incubation times to maintain optimal particle size and minimize toxicity, using systems that can handle large volumes efficiently.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If large volumes of transfection cocktail are prepared in advance, then the quantity of substance is sufficient for industrial scale, but the incubation time increases causing particle size enlargement and reduced transfection efficiency
Solution Approach 1:
The patent applies preliminary action by pre-mixing transfection reagent and nucleic acid in separate solutions before the actual transfection event. This allows the reagents to be prepared in advance in a controlled manner, then rapidly combined and delivered to cells, preventing excessive incubation time while ensuring sufficient quantity for industrial scale operations.
Solution Approach 2:
The patent segments the transfection cocktail preparation into separate components (transfection reagent solution and nucleic acid solution) that are mixed just before application. This segmentation prevents premature particle formation and extends the usable time window for large-volume preparations while maintaining high transfection efficiency.
2Reliability
If transfection cocktail is delivered rapidly to cells, then transfection efficiency is maintained, but the complexity of the delivery system increases for industrial scale
Solution Approach 1:
The patent merges the preparation and delivery functions into a single integrated system that prepares and applies the transfection cocktail continuously. This consolidation reduces the need for separate pre-preparation and delivery systems, maintaining simplicity while enabling rapid delivery of large volumes to cells for high transfection efficiency.
3Stability of the object's composition
If extended incubation is allowed, then thorough mixing is achieved, but particle size increases reducing transfection efficiency and increasing toxicity
Solution Approach 1:
The patent implements continuous mixing and rapid delivery as a continuous process rather than allowing extended static incubation. The transfection reagent and nucleic acid are continuously mixed and immediately delivered to cells, achieving thorough mixing through continuous motion while preventing particle size enlargement and toxicity associated with extended incubation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach maintains high transfection efficiency and productivity, even at industrial scales, by minimizing delays and ensuring uniform distribution of the transfection cocktail, thereby enhancing the production of biological products such as recombinant AAV vectors.
Implementation Method 1
transfection reagent is typically mixed in a solution with the nucleic acid of interest, forming a so-called transfection cocktail... chemically-based transfection reagents are rich in positive charges that can shield the negatively charged phosphate backbone of DNA or RNA
Implementation Method 2
chemically-based transfection reagents are rich in positive charges that can shield the negatively charged phosphate backbone of DNA or RNA, thereby facilitating entry of the particles of complexed transfection reagent and nucleic acid into cells
Data Source
AI summary
The present disclosure provides improved methods and systems for transfecting host cells with nucleic acids, such as plasmid DNA, for purposes of efficiently producing biological products, such as AAV vectors, at large scale.